腸内細菌由来の生理活性物質がアレルギー性疾患の発症に与える影響について.
- Published in:
- Folia Pharmacologica Japonica, 2022, v. 157, n. 1, p. 85, doi. 10.1254/fpj.21088
- By:
- Publication type:
- Article
Works matching IS 00155691 AND DT 2022 AND VI 157 AND IP 1
Results: 16
1
2
肺線維症における Th2 サイトカイン.
- Published in:
- Folia Pharmacologica Japonica, 2022, v. 157, n. 1, p. 86, doi. 10.1254/fpj.21096
- By:
- Publication type:
- Article
3
特集：筋研究の新展開：疾患治療，創薬に向けて.
- Published in:
- Folia Pharmacologica Japonica, 2022, v. 157, n. 1, p. 3, doi. 10.1254/fpj.21073
- By:
- Publication type:
- Article
4
特集: COVID-19 治療薬 ドラッグリポジショニングによる承認への挑戦.
- Published in:
- Folia Pharmacologica Japonica, 2022, v. 157, n. 1, p. 26, doi. 10.1254/fpj.21054
- By:
- Publication type:
- Article
5
Pharmacological property, mechanism of action and clinical study results of Pabinafusp Alfa (Genetical Recombination) (IZCARGO® I.V. Infusion 10 mg) as the therapeutic for Mucopolysaccharidosis type-II (Hunter syndrome).
- Published in:
- Folia Pharmacologica Japonica, 2022, v. 157, n. 1, p. 62, doi. 10.1254/fpj.21080
- By:
- Publication type:
- Article
6
Pharmacological profile, clinical efficacy, and safety of Follitropin Delta produced by recombinant DNA technology in a human cell line (REKOVELLE® PEN for S.C. Injection 12 μg, 36 μg, 72 μg).
- Published in:
- Folia Pharmacologica Japonica, 2022, v. 157, n. 1, p. 76, doi. 10.1254/fpj.21079
- By:
- Publication type:
- Article
7
In vivo integrated safety assessment of the cardiovascular system in drug development.
- Published in:
- Folia Pharmacologica Japonica, 2022, v. 157, n. 1, p. 47, doi. 10.1254/fpj.21075
- By:
- Publication type:
- Article
8
Therapeutic effects of novel type1 ryanodine receptor inhibitor on skeletal muscle diseases.
- Published in:
- Folia Pharmacologica Japonica, 2022, v. 157, n. 1, p. 15, doi. 10.1254/fpj.21068
- By:
- Publication type:
- Article
9
Pharmacological and clinical profile of Onasemnogene Aveparvovec, the first gene therapy for spinal muscular atrophy (SMA).
- Published in:
- Folia Pharmacologica Japonica, 2022, v. 157, n. 1, p. 53, doi. 10.1254/fpj.21066
- By:
- Publication type:
- Article
10
How to evaluate skeletal muscle function: suggestion from studies on skeletal muscle fatigue.
- Published in:
- Folia Pharmacologica Japonica, 2022, v. 157, n. 1, p. 9, doi. 10.1254/fpj.21065
- By:
- Publication type:
- Article
11
Regulation of localization and function of L-type calcium channels by junctophilins.
- Published in:
- Folia Pharmacologica Japonica, 2022, v. 157, n. 1, p. 4, doi. 10.1254/fpj.21064
- By:
- Publication type:
- Article
12
Remdesivir for COVID-19.
- Published in:
- Folia Pharmacologica Japonica, 2022, v. 157, n. 1, p. 31, doi. 10.1254/fpj.21058
- By:
- Publication type:
- Article
13
Involvement of muscle stem cell in skeletal muscle hypertrophy induced by mechanical loading and drugs.
- Published in:
- Folia Pharmacologica Japonica, 2022, v. 157, n. 1, p. 23, doi. 10.1254/fpj.21047
- By:
- Publication type:
- Article
14
COVID-19 drug candidate pipeline, an overview.
- Published in:
- Folia Pharmacologica Japonica, 2022, v. 157, n. 1, p. 27, doi. 10.1254/fpj.21043
- By:
- Publication type:
- Article
15
Drug repositioning to combat COVID-19 using artificial intelligence system.
- Published in:
- Folia Pharmacologica Japonica, 2022, v. 157, n. 1, p. 41, doi. 10.1254/fpj.21042
- By:
- Publication type:
- Article
16
Contribution to development of remedies for COVID-19: focusing on Eritoran.
- Published in:
- Folia Pharmacologica Japonica, 2022, v. 157, n. 1, p. 38, doi. 10.1254/fpj.21041
- By:
- Publication type:
- Article